Drug factory · FDA FEI 1015040
Nexair, LLC
150 Stockton St, Jacksonville, FL, United States
Problems found, fixed voluntarily at FDA's last inspection, Jul 11, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2010: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 11, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | 2 |
| Oct 16, 2012 | No problems found | Drug Quality Assurance | — |
| May 3, 2010 | No problems found | Drug Quality Assurance | — |
What inspectors wrote down
From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.
Jul 11, 2024 inspection
- Buildings not maintained in good state of repair 21 CFR 211.58
Buildings used in the manufacturing, processing, packing and holding of a drug product are not maintained in a good state of repair. - Calibration/Inspection/Checking not done 21 CFR 211.68(a)
Routine checking of electronic equipment is not performed according to a written program designed to assure proper performance.
Registered with FDA for: manufacture.